ABBV
Price
$256.10
Change
+$2.72 (+1.07%)
Updated
Jul 21 closing price
Capitalization
452.48B
9 days until earnings call
Intraday BUY SELL Signals
JNJ
Price
$255.26
Change
+$4.65 (+1.86%)
Updated
Jul 22, 12:28 PM (EDT)
Capitalization
603.27B
90 days until earnings call
Intraday BUY SELL Signals
NVS
Price
$153.87
Change
+$4.31 (+2.88%)
Updated
Jul 21 closing price
Capitalization
294.86B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABBV or JNJ or NVS

ABBV vs JNJ vs NVS Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2026
Stock price -- (ABBV: $256.10JNJ: $250.61NVS: $153.87)
Brand notoriety: ABBV and JNJ are notable and NVS is not notable
The three companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 62%, JNJ: 84%, NVS: 135%
Market capitalization -- ABBV: $452.48B, JNJ: $603.27B, NVS: $294.86B
$ABBV is valued at $452.48B, while JNJ has a market capitalization of $603.27B, and NVS's market capitalization is $294.86B. The market cap for tickers in this @Pharmaceuticals: Major ranges from $1.05T to $0. The average market capitalization across the @Pharmaceuticals: Major industry is $193.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green whileJNJ’s FA Score has 4 green FA rating(s), and NVS’s FA Score reflects 4 green FA rating(s).

  • ABBV’s FA Score: 4 green, 1 red.
  • JNJ’s FA Score: 4 green, 1 red.
  • NVS’s FA Score: 4 green, 1 red.
According to our system of comparison, JNJ and NVS are a better buy in the long-term than ABBV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 5 TA indicator(s) are bullish while JNJ’s TA Score has 4 bullish TA indicator(s), and NVS’s TA Score reflects 6 bullish TA indicator(s).

  • ABBV’s TA Score: 5 bullish, 4 bearish.
  • JNJ’s TA Score: 4 bullish, 5 bearish.
  • NVS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, NVS is a better buy in the short-term than ABBV, which in turn is a better option than JNJ.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а +5.37% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -1.28% , and NVS (@Pharmaceuticals: Major) price fluctuated +2.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.88%. For the same industry, the average monthly price growth was +3.62%, and the average quarterly price growth was +4.98%.

Reported Earning Dates

ABBV is expected to report earnings on Jul 31, 2026.

JNJ is expected to report earnings on Oct 20, 2026.

NVS is expected to report earnings on Oct 27, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+1.88% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($603B) has a higher market cap than ABBV($452B) and NVS($295B). ABBV has higher P/E ratio than JNJ and NVS: ABBV (125.54) vs JNJ (29.07) and NVS (22.04). JNJ YTD gains are higher at: 22.441 vs. NVS (14.978) and ABBV (14.734). JNJ has higher annual earnings (EBITDA): 33.7B vs. NVS (22.4B) and ABBV (16.9B). NVS has less debt than JNJ and ABBV: NVS (47B) vs JNJ (55B) and ABBV (72.9B). JNJ has higher revenues than ABBV and NVS: JNJ (96.4B) vs ABBV (62.8B) and NVS (56.6B).
ABBVJNJNVS
Capitalization452B603B295B
EBITDA16.9B33.7B22.4B
Gain YTD14.73422.44114.978
P/E Ratio125.5429.0722.04
Revenue62.8B96.4B56.6B
Total CashN/A22.1B6.98B
Total Debt72.9B55B47B
FUNDAMENTALS RATINGS
ABBV vs JNJ vs NVS: Fundamental Ratings
ABBV
JNJ
NVS
OUTLOOK RATING
1..100
857768
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
14
Undervalued
10
Undervalued
PROFIT vs RISK RATING
1..100
566
SMR RATING
1..100
13628
PRICE GROWTH RATING
1..100
81248
P/E GROWTH RATING
1..100
171425
SEASONALITY SCORE
1..100
307550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVS's Valuation (10) in the Pharmaceuticals Major industry is in the same range as JNJ (14) and is somewhat better than the same rating for ABBV (62). This means that NVS's stock grew similarly to JNJ’s and somewhat faster than ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is in the same range as NVS (6) and is in the same range as JNJ (6). This means that ABBV's stock grew similarly to NVS’s and similarly to JNJ’s over the last 12 months.

ABBV's SMR Rating (1) in the Pharmaceuticals Major industry is in the same range as NVS (28) and is somewhat better than the same rating for JNJ (36). This means that ABBV's stock grew similarly to NVS’s and somewhat faster than JNJ’s over the last 12 months.

ABBV's Price Growth Rating (8) in the Pharmaceuticals Major industry is in the same range as JNJ (12) and is somewhat better than the same rating for NVS (48). This means that ABBV's stock grew similarly to JNJ’s and somewhat faster than NVS’s over the last 12 months.

JNJ's P/E Growth Rating (14) in the Pharmaceuticals Major industry is in the same range as ABBV (17) and is in the same range as NVS (25). This means that JNJ's stock grew similarly to ABBV’s and similarly to NVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVJNJNVS
RSI
ODDS (%)
Bearish Trend 1 day ago
37%
Bearish Trend 1 day ago
44%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
46%
Bullish Trend 1 day ago
55%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
54%
Bearish Trend 1 day ago
45%
MACD
ODDS (%)
Bearish Trend 1 day ago
43%
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
40%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
42%
Bullish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
50%
Advances
ODDS (%)
Bullish Trend 6 days ago
59%
Bullish Trend 6 days ago
45%
Bullish Trend 6 days ago
52%
Declines
ODDS (%)
Bearish Trend 9 days ago
48%
Bearish Trend 8 days ago
42%
Bearish Trend 9 days ago
46%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
38%
Bearish Trend 1 day ago
45%
Bullish Trend 1 day ago
59%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
44%
Bullish Trend 1 day ago
47%
View a ticker or compare two or three
Interact to see
Advertisement
ABBV
Daily Signal:
Gain/Loss:
JNJ
Daily Signal:
Gain/Loss:
NVS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MPGFX195.85N/A
N/A
Mairs & Power Fund
HADAX30.38N/A
N/A
Hartford Balanced HLS IA
VSSVX11.49N/A
N/A
VALIC Company I Small Cap Core
ESCGX16.15N/A
N/A
Ashmore Emerging Markets Equity ESG C
VVSGX19.96N/A
N/A
VALIC Company I Small Cap Growth

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with BMY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then BMY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
+1.07%
BMY - ABBV
53%
Loosely correlated
+1.28%
NVS - ABBV
49%
Loosely correlated
+2.88%
AMGN - ABBV
46%
Loosely correlated
+0.57%
MRK - ABBV
45%
Loosely correlated
+1.50%
JNJ - ABBV
42%
Loosely correlated
+0.72%
More

NVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVS has been closely correlated with GSK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVS jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVS
1D Price
Change %
NVS100%
+2.88%
GSK - NVS
66%
Closely correlated
+1.48%
AMGN - NVS
56%
Loosely correlated
+0.57%
BMY - NVS
56%
Loosely correlated
+1.28%
MRK - NVS
55%
Loosely correlated
+1.50%
PFE - NVS
51%
Loosely correlated
+0.77%
More